ACE2 and COVID-19: The authors showed that the APOE ε4 allele downregulates ACE2 protein expression in vitro and in vivo and consequently decreases the conversion of Angiotensin II to Angiotensin 1–7, which may introduce a potential mechanism by which APOE ε4 is associated with COVID-19 severity [26].